Download App
Help CenterSubscribe
Money Works 4 Me Logo MoneyWorks4Me
Talk to Advisor
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

Nath Bio-Genes (India) Ltd (NATHBIOGEN)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 537291 NSE: NATHBIOGEN Agriculture | Small Cap | Nath Bio-Genes (I) Share Price

₹147.35 0.00 (0.00%)

As on 23-Sep'26 16:59

Nath Bio-Genes (India) Ltd (NATHBIOGEN)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 537291 NSE: NATHBIOGEN Agriculture | Small Cap | Nath Bio-Genes (I) Share Price

₹147.35 0.00 (0.00%)

As on 23-Sep'26 16:59

Key Metrics
Valuation Multiples
Market Cap
₹280 Cr.
Current Price
₹147.4
52-Week Low / High
₹127 / 207
TTM EPS
₹19.3
TTM Sales
₹490 Cr.
Book Value per Share
₹375
P/E Ratio
7.65
In line with its 5-year historical median
Industry PE
16
Price to Book (P/B)
0.39
Lower than its 5-year historical median
Price to Sales (P/S)
0.57
Lower than its 5-year historical median
EV/EBITDA
5.98
Lower than its 5-year historical median
Dividend Yield
1.36%
Profitability Efficiency
Return on Equity (ROE)
6.28%
Underperforms industry median
Return on Capital Employed (ROCE)
7.88%
Underperforms industry median
Return on Assets (ROA)
3.92%
Operating Profit Margin
11.9%
Net Profit Margin
9.35%
Gross Profit Margin
9.9%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
19.12%
Operating Profit Growth (1 Year)
Improving versus 3-year growth rate
5.11%
Net Profit Growth (1 Year)
Improving versus 3-year growth rate
7.85%
Asset Quality
Promoter Holding
45.60%
Pledged shares (%) of Promoter's holding (%)
13.78%
Reserves
₹694 Cr.
Equity
₹19 Cr.
Face Value
₹10
All Time Low / High
₹38.90 / 585.00

Nath Bio-Genes (India) stock performance

Key Ratios
mw4me loader

Check Before You Invest

Check Before You Invest

Quality

Somewhat Good
Check detailed performance

Valuation

Undervalued

Check Valuation charts

Price Trend

Weak
Check Price chart
Q.1 Is Nath Bio-Genes (India) Ltd a good quality company?
Nath Bio-Genes (India) Ltd is a average quality company, based on a somewhat consistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

View More

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

View More
How does Nath Bio-Genes (India) Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Nath Bio-Genes (India) Ltd vs industry peers?
Nath Bio-Genes (India) Ltd revenue CAGR is 24.11%, compared to the industry median CAGR of 0%, indicating faster growth and gaining its market share.
Q.1 Promoter shareholding and pledge status of Nath Bio-Genes (India) Ltd?
Promoters hold 45.60% of the Nath Bio-Genes (India) Ltd, with 13.78% of their stake pledged, indicating high pledge risk.
Q.1 Stock return of Nath Bio-Genes (India) Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 4.2% based on the current price.
View More

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Nath Bio-Genes (India) Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation ⓘ

Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26TTM
ROCE % ⓘ9.5%9.2%8.3%9.2%9.8%-7.8%7.1%7.3%7.3%8%-
Value Creation
Index ⓘ		-0.3-0.3-0.4-0.3-0.3-1.6-0.5-0.5-0.5-0.4-

Growth Parameters ⓘ
Sales ⓘ170192231280308278301333362432474
Sales YoY Gr.-12.8%20.5%21.2%9.9%-9.5%8.2%10.4%8.9%19.1%-
Adj EPS ⓘ10.115.520.126.429.3-35.518.321.122.223.125.2
YoY Gr.-52.6%30%31.5%10.9%-221.2%NA15.2%5.3%3.8%-
BVPS (₹) ⓘ189.5246.9267.1293.4322.7285.2301.7321.3341.3362.8379.9
Adj Net
Profit ⓘ		16.229.438.250.255.7-67.534.940.242.343.948
Cash Flow from Ops. ⓘ3.3-47-22.99.51.117.138.474.726.8-13.9-
Debt/CF from Ops. ⓘ22.1-0.7-2.57.490.65.52.71.54.2-8.8-

CAGR ⓘ

9 Years 5 Years 3 Years 1 Years
Sales ⓘ10.9%7%12.7%19.1%
Adj EPS ⓘ9.6%-4.7%8%3.8%
BVPSⓘ7.5%2.4%6.3%6.3%
Share Price 4.2% -14.7% -10.9% -14.3%

Key Financial Parameters ⓘ

Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26TTM
Return on
Equity % ⓘ		7.67.67.89.49.5-11.76.36.86.76.66.8
Op. Profit
Mgn % ⓘ		17.121.118.819.621.813.416.315.214.812.312.2
Net Profit
Mgn % ⓘ		9.615.316.61818.1-24.211.612.111.710.210.1
Debt to
Equity ⓘ		0.20.10.10.10.20.20.20.20.20.2-
Working Cap
Days ⓘ		500520553552572652600577614605771
Cash Conv.
Cycle ⓘ		263264280271301360312297299299403

Valuation of Nath Bio-Genes (I) - Consolidated

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *16.3816.3816.3816.3816.3813.7813.7813.7813.7813.78
* Pledged shares as % of Promoter's holding (%)

Financials

PARTICULARSMar'12Mar'13Mar'22Mar'23Mar'24Mar'25Mar'26
Sales124138278301333365445
Operating Expenses ⓘ + 109118241252283315392
Manufacturing Costs5666129112139233327
Material Costs4-2917-9-90-105
Employee Cost 9102523283235
Other Costs ⓘ 414379100125140136
Operating Profit ⓘ 15203749505053
Operating Profit Margin (%) 11.8%14.5%13.4%16.3%15.0%13.7%11.8%
Other Income ⓘ + 1121158
Exceptional Items ⓘ 00-890316
Interest ⓘ 24111091116
Depreciation ⓘ 5533344
Profit Before Tax ⓘ 912-6336424146
Tax ⓘ -0141225
Profit After Tax 912-6735403942
PAT Margin (%) 7.4%8.5%-24.2%11.6%11.9%10.6%9.4%
Adjusted EPS (₹)5.87.3-35.518.420.920.321.9
Dividend Payout Ratio (%)0%0%-5.60%10.90%9.60%9.90%9.10%
PARTICULARSMar'12Mar'13Mar'22Mar'23Mar'24Mar'25Mar'26

Equity and Liabilities

Shareholders Fund + 4657542573610644680
Share Capital ⓘ 16161919191919
Reserves ⓘ 3041523554591625661
Debt +91892104109121137
Long Term Debt111051317
Short Term Debt81792104104108119
Minority Interest00-00000
Trade Payables162843284379131
Others Liabilities ⓘ 48546387118181149
Total Liabilities ⓘ 1191577397938801,0261,097

Fixed Assets

Net Fixed Assets ⓘ +2138245244249250249
Gross Block5677267270274279275
Accumulated Depreciation35392225252926
CWIP ⓘ 0000000
Investments ⓘ 1055666
Inventories6677220208230338451
Trade Receivables12218697948985
Cash Equivalents 32438778976
Others Assets ⓘ 1619179200223254230
Total Assets ⓘ 1191577397938801,0261,097
PARTICULARSMar'12Mar'13Mar'22Mar'23Mar'24Mar'25Mar'26
Cash Flow From Operating Activity ⓘ + 01417387518-13
PBT ⓘ 012-6336424146
Adjustment ⓘ 0810213101311
Changes in Working Capital ⓘ 0-6-19-1023-35-69
Tax Paid ⓘ 0-1-3-1-0-1-1
Cash Flow From Investing Activity ⓘ + 0-21-20-3-27-43
Capex 0-21-1-3-27-8-3
Net Investments 01-0-0-10-0
Others ⓘ 0-0-19-0047
Cash Flow From Financing Activity ⓘ + 06-22-2-8-2-4
Net Proceeds from Shares ⓘ 0000000
Net Proceeds from Borrowing ⓘ 000-0284
Interest Paid ⓘ 0-4-11-10-9-10-16
Dividend Paid ⓘ 00-4-4-4-4-4
Others ⓘ 09-8133412
Net Cash Flow ⓘ 0-1-25343911-13
PARTICULARSMar'12Mar'13Mar'22Mar'23Mar'24Mar'25Mar'26
Ratios
ROE (%)20.1222.76-22.486.286.76.156.28
ROCE (%)19.0923.88-14.847.097.266.97.88
Asset Turnover Ratio1.0410.620.390.40.380.42
PAT to CFO Conversion(x)01.17N/A1.091.880.46-0.31
Working Capital Days
Receivable Days36.7044.3069.90110.70105.1091.6071.50
Inventory Days193.70189.40195.10259.30240.40284.20323.30
Payable Days1,576.70-4,219.201,503.40744.30-1,457.20-249-367.20

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Nath Bio-Genes (India) Ltd FAQs

The current trading price of Nath Bio-Genes (I) on 23-Sep-2026 16:59 is ₹147.3.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 22-Sep-2026 the market cap of Nath Bio-Genes (I) stood at ₹280.0 Cr

The latest P/E ratio of Nath Bio-Genes (I) as of 22-Sep-2026 is 5.85.

The latest P/B ratio of Nath Bio-Genes (I) as of 22-Sep-2026 is 0.39.

The 52-week high of Nath Bio-Genes (I) is ₹207.0 and the 52-week low is ₹126.8.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Nath Bio-Genes (I) is ₹474 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Nath Bio-Genes (India) Ltd is a average quality company.

The key valuation ratios of Nath Bio-Genes (India) Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Nath Bio-Genes (India) Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Nath Bio-Genes (India) Ltd

No data to display
You have 49 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now